Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,039.84
892.00
985.93
813.86
917.55
547.31
843.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,039.84
892.00
985.93
813.86
917.55
547.31
843.88
Raw Material Cost
217.50
266.36
270.50
240.40
258.17
204.40
182.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.98
18.62
18.62
17.24
21.65
13.94
9.27
Selling and Distribution Expenses
422.23
425.81
397.33
363.23
336.65
164.00
395.93
Other Expenses
7.95
10.90
8.94
11.36
8.11
9.26
10.71
Total Expenditure (Excl Depreciation)
737.17
819.75
775.82
734.48
697.61
474.92
695.31
Operating Profit (PBDIT) excl Other Income
302.7
72.2
210.10000000000002
79.4
219.89999999999998
72.4
148.6
Other Income
-4.34
3.06
-0.84
13.84
16.16
16.16
2.47
Operating Profit (PBDIT)
286.20
202.63
337.62
220.22
360.11
156.89
248.00
Interest
17.98
18.62
18.62
17.24
21.65
13.94
9.27
Exceptional Items
24.27
-10.66
27.99
0.58
-76.60
-73.12
46.81
Gross Profit (PBDT)
822.34
625.64
715.43
573.46
659.38
342.91
660.91
Depreciation
0.00
139.83
139.83
135.55
135.55
102.09
102.09
Profit Before Tax
292.49
33.52
207.16
68.01
126.31
-32.26
183.45
Tax
51.31
39.59
31.46
29.42
27.69
-19.49
-7.29
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
235.92
-11.60
177.04
39.81
100.09
-13.66
192.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
235.92
-11.60
177.04
39.81
100.09
-13.66
192.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.76
-5.19
-4.74
-4.56
-4.63
-4.52
-3.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
231.16
-16.80
172.30
35.24
95.46
-18.17
189.03
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,794.86
6,595.16
5,843.40
5,594.36
5,543.68
5,573.81
5,636.95
Earnings per share (EPS)
0.56
-0.03
0.42
0.09
0.24
-0.03
0.46
Diluted Earnings per share
0.56
-0.03
0.42
0.09
0.24
-0.03
0.46
Operating Profit Margin (Excl OI)
27.94%
6.7%
20.15%
8.7%
22.71%
7.06%
17.0%
Gross Profit Margin
28.13%
19.43%
35.19%
25.01%
28.54%
12.76%
33.84%
PAT Margin
22.69%
-1.3%
17.96%
4.89%
10.91%
-2.5%
22.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 16.57% vs -9.52% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 1,476.19% vs -109.75% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 45.54% vs -41.03% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -3.23% vs 0.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Betta Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,039.84
0
1,039.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,039.84
0
1,039.84
Raw Material Cost
217.50
0
217.50
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.98
0
17.98
Selling and Distribution Expenses
422.23
0
422.23
Other Expenses
7.95
0.00
7.95
Total Expenditure (Excl Depreciation)
737.17
0
737.17
Operating Profit (PBDIT) excl Other Income
302.67
0.00
302.67
Other Income
-4.34
0
-4.34
Operating Profit (PBDIT)
286.20
0
286.20
Interest
17.98
0
17.98
Exceptional Items
24.27
0
24.27
Gross Profit (PBDT)
822.34
0
822.34
Depreciation
0.00
0
0.00
Profit Before Tax
292.49
0
292.49
Tax
51.31
0
51.31
Provisions and contingencies
0
0
0.00
Profit After Tax
235.92
0
235.92
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
235.92
0
235.92
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.76
0
-4.76
Other related items
0.00
0.00
0.00
Consolidated Net Profit
231.16
0
231.16
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,794.86
0
6,794.86
Earnings per share (EPS)
0.56
0
0.56
Diluted Earnings per share
0.56
0
0.56
Operating Profit Margin (Excl OI)
27.94%
0%
0.00
27.94%
Gross Profit Margin
28.13%
0%
0.00
28.13%
PAT Margin
22.69%
0%
0.00
22.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 103.98 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 16.57% vs -9.52% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 13.32% vs 24.71% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 23.12 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 1,476.19% vs -109.75% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 142.09% vs 1.81% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.05 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 45.54% vs -41.03% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -15.55% vs 78.15% in Mar 2025
Quarterly - Interest
Interest 1.80 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -3.23% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -16.67% vs 96.36% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.94%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
